The Formulary Information Exchange (The F.I.X.) is an online drug information service available to subscribers of The Formulary Monograph Service. In this column, we present samples of recent dialog on The F.I.X. If you would like more information on The Formulary Monograph Service or The F.I.X., please call 800-322-4349.
Get full access to this article
View all access options for this article.
References
1.
FauserA., DuclosB., ChemaissaniA.Therapeutic equivalence of a single oral doses of dolasetron mesylate and multiple doses of ondansetron for the prevention of emesis after moderately emetogenic chemotherapy. European J Cancer.1996; 32A (9) 1523–29.
2.
HeskethP., NavariR., GroteT.Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and ntravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. J Clin Oncol.1996; 4(8) 2242–9.
